The Australian sharemarket has extended a late end of year rally, sidestepping a tech selloff in the US overnight as volumes ...
Zacks.com on MSN21h
What Awaits These 4 Biotech Stocks That More Than Doubled in 2024The drug and biotech sector had a turbulent year in 2024, starting strong but losing momentum in the second half. This ...
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback